Founded in 2009 in Sydney, SpeeDx’ current IVD portfolio consists of two multiplex assays: ResistancePlus™ MG and PlexPCR™ HSV-1&2, VZV. The company is also developing a pipeline of multiplex assays including those for Respiratory viruses; HSV-1&2, VZV & Syphilis and STI panels.
Overcoming the challenge and time-consuming process of result interpretation
Defining assay-specific results: sometimes amplification means more than just detection
Clearing the pathway to support customer questions about certain results
In-house, spreadsheet-based interpretation software required manual manipulation of raw data and had limited security features
Manual copy-paste of raw data created potential for human errors
Supporting customers often involved back-and-forth mailing of result files
Completely validated, device-independent and artificially intelligent PCR result interpretation software
A secure, standardized & audit-trailed workflow with little to no margin for user error
Support is always just a click away, a fully trained SpeeDx team can help customers where they need it the most
No laborious software projects
“The plug-and-play foundation of FastFinder enabled fast turnaround of our software product. Although it is a generic software, the team attempted to incorporate our feedback into the development process." Litty Tan, R&D Director at SpeeDx.
A turnkey solution
CE-IVD compliant interpretation workflow.
Before, SpeeDx end-users would use industrial software for the interpretation and an MS Excel based analysis software to automate sample interpretation. However, the format wasn’t as user-friendly and still required some manual transferring of raw data.
CEO at SpeeDx Ltd.
Since FastFinder is compatible with multiple PCR platforms, we don't have to tie ourselves to a single platform. This empowers us to expand our product offerings to more users and laboratories.